JPMORGAN CHASE & CO - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$699
-47.6%
3720.0%0.00%
Q2 2023$1,335
+33.5%
3720.0%0.00%
Q1 2023$1,000
+99900.0%
3720.0%0.00%
Q4 2022$1
-99.9%
3720.0%0.00%
Q3 2022$1,000
-98.3%
372
-98.6%
0.00%
Q2 2022$59,000
-6.3%
26,813
+36.0%
0.00%
Q1 2022$63,000
-79.3%
19,711
-72.8%
0.00%
Q4 2021$304,000
+141.3%
72,386
+364.0%
0.00%
Q3 2021$126,000
+3.3%
15,602
-3.1%
0.00%
Q2 2021$122,000
-10.3%
16,104
+2.7%
0.00%
Q1 2021$136,000
-6.2%
15,676
-13.8%
0.00%
Q4 2020$145,000
+16.9%
18,196
+18.8%
0.00%
Q3 2020$124,000
+7.8%
15,313
+32.0%
0.00%
Q2 2020$115,000
+51.3%
11,598
+18.6%
0.00%
Q1 2020$76,000
-51.0%
9,782
-75.7%
0.00%
Q4 2019$155,000
+210.0%
40,252
+301.0%
0.00%
Q3 2019$50,000
-10.7%
10,038
+19.4%
0.00%
Q2 2019$56,000
+1.8%
8,410
+15.9%
0.00%
Q1 2019$55,000
-32.1%
7,256
-28.0%
0.00%
Q4 2018$81,000
-93.6%
10,081
-89.7%
0.00%
Q3 2018$1,267,000
-43.8%
98,188
-50.3%
0.00%
Q2 2018$2,253,000
+5676.9%
197,580
+3193.0%
0.00%
Q4 2017$39,000
+1850.0%
6,000
+2005.3%
0.00%
Q3 2017$2,000
+100.0%
2850.0%0.00%
Q2 2017$1,000
-85.7%
285
-82.4%
0.00%
Q1 2017$7,000
-36.4%
1,620
-19.0%
0.00%
Q4 2016$11,000
-21.4%
2,001
-5.6%
0.00%
Q3 2016$14,000
+55.6%
2,119
+3.8%
0.00%
Q2 2016$9,000
+12.5%
2,0420.0%0.00%
Q1 2016$8,000
-42.9%
2,042
-18.7%
0.00%
Q4 2015$14,0002,5110.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
CM Management, LLC 675,000$918,0001.02%
Sargent Investment Group, LLC 1,108,233$2,028,0000.63%
Skylands Capital, LLC 2,347,034$3,192,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,000$344,0000.37%
Avenir Corp 2,314,854$3,148,0000.33%
Granahan Investment Management 1,511,029$2,055,0000.07%
ACT CAPITAL MANAGEMENT, LLC 35,000$48,0000.07%
Winning Points Advisors, LLC 22,900$33,0000.04%
Cowen Prime Advisors LLC 42,200$57,0000.03%
Seelaus Asset Management LLC 23,900$33,0000.03%
View complete list of CYTOSORBENTS CORP shareholders